Shopping Cart 0
Cart Subtotal
AED 0

Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 0

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 0

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 0

Details

Summary

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and women's health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The company's drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets products in the Middle East, Latin America, Africa, Europe and Asia. Acino is headquartered in Zurich, Switzerland.

Acino International AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9

Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Acino International AG, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Acino Pharma Acquires Three Products from Tabuk Pharma 11

Acino International Acquires Manufacturing Business from Takeda Pharma 12

Norgine Divests its MENA Operations and Product Rights to Acino 13

Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14

Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For USD 123 Million 15

Private Equity 17

Avista Capital And Nordic Capital To Acquire Acino For USD 439.93 Million 17

Partnerships 18

Acino International Enters into Distribution Agreement with Merck 18

Licensing Agreements 19

Acino Pharma Enters into Licensing Agreement with AFT Pharma 19

Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 20

Asset Transactions 21

Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 21

Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 22

Acquisition 23

Acino Pharma Acquires Litha Healthcare from Endo International 23

Acino Pharma Acquires Pharma Start 24

Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For USD 60.7 Million 25

Acino International AG-Key Competitors 27

Acino International AG-Key Employees 28

Acino International AG-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Corporate Communications 31

Jun 04, 2018: Steffen Saltofte appointed CEO Acino Group 31

Feb 15, 2017: Appointment of Mario Ricard as COO and member of the Executive Committee 32

Jan 23, 2017: Resignation of Barthold Piening, Chief Operations Officer 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Acino International AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Acino International AG, Deals By Therapy Area, 2012 to YTD 2018 8

Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9

Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Acino Pharma Acquires Three Products from Tabuk Pharma 11

Acino International Acquires Manufacturing Business from Takeda Pharma 12

Norgine Divests its MENA Operations and Product Rights to Acino 13

Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14

Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For USD 123 Million 15

Avista Capital And Nordic Capital To Acquire Acino For USD 439.93 Million 17

Acino International Enters into Distribution Agreement with Merck 18

Acino Pharma Enters into Licensing Agreement with AFT Pharma 19

Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 20

Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 21

Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 22

Acino Pharma Acquires Litha Healthcare from Endo International 23

Acino Pharma Acquires Pharma Start 24

Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For USD 60.7 Million 25

Acino International AG, Key Competitors 27

Acino International AG, Key Employees 28

Acino International AG, Subsidiaries 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and women's health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The company's drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets products in the Middle East, Latin America, Africa, Europe and Asia. Acino is headquartered in Zurich, Switzerland.

Acino International AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9

Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Acino International AG, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Acino Pharma Acquires Three Products from Tabuk Pharma 11

Acino International Acquires Manufacturing Business from Takeda Pharma 12

Norgine Divests its MENA Operations and Product Rights to Acino 13

Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14

Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For USD 123 Million 15

Private Equity 17

Avista Capital And Nordic Capital To Acquire Acino For USD 439.93 Million 17

Partnerships 18

Acino International Enters into Distribution Agreement with Merck 18

Licensing Agreements 19

Acino Pharma Enters into Licensing Agreement with AFT Pharma 19

Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 20

Asset Transactions 21

Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 21

Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 22

Acquisition 23

Acino Pharma Acquires Litha Healthcare from Endo International 23

Acino Pharma Acquires Pharma Start 24

Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For USD 60.7 Million 25

Acino International AG-Key Competitors 27

Acino International AG-Key Employees 28

Acino International AG-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Corporate Communications 31

Jun 04, 2018: Steffen Saltofte appointed CEO Acino Group 31

Feb 15, 2017: Appointment of Mario Ricard as COO and member of the Executive Committee 32

Jan 23, 2017: Resignation of Barthold Piening, Chief Operations Officer 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Acino International AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Acino International AG, Deals By Therapy Area, 2012 to YTD 2018 8

Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9

Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Acino Pharma Acquires Three Products from Tabuk Pharma 11

Acino International Acquires Manufacturing Business from Takeda Pharma 12

Norgine Divests its MENA Operations and Product Rights to Acino 13

Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14

Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For USD 123 Million 15

Avista Capital And Nordic Capital To Acquire Acino For USD 439.93 Million 17

Acino International Enters into Distribution Agreement with Merck 18

Acino Pharma Enters into Licensing Agreement with AFT Pharma 19

Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 20

Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 21

Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 22

Acino Pharma Acquires Litha Healthcare from Endo International 23

Acino Pharma Acquires Pharma Start 24

Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For USD 60.7 Million 25

Acino International AG, Key Competitors 27

Acino International AG, Key Employees 28

Acino International AG, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS